Proteomics International Laboratories Ltd (PIQLF) Investor Presentation Morgan Stanley Alpha ex-100 Conference

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce its Managing Director Dr Richard Lipscombe and Chief Commercial Officer Mr Phillip Prather will give the attached investor briefing at the Alpha ex-100 Conference hosted by Morgan Stanley in Sydney today.

*To view the presentation, please visit:
https://abnnewswire.net/lnk/Y8JZ4PHE

Dr Richard Lipscombe
Managing Director
Proteomics International Laboratories Ltd
T: +61 8 9389 1992
E: enquiries@proteomicsinternational.com

Dirk van Dissel 
Investor Relations and Corporate Advisor
Candour Advisory
T: +61 408 326 367 
E: dirk@candouradvisory.com.au

Matthew Wright
Media and Public Relations
NWR Communications
T: +61 451 896 420
E: matt@nwrcommunications.com.au

News Provided by ABN Newswire